Clinical Trials Browser

Phase 2 × Interventional × rezivertinib × Clear all

NCT03812809 2022-05-19

A Phase IIb Study of BPI-7711 Capsule in Non-small Cell Lung Cancer Patients With T790M Mutation Positive

Phase 2 Completed

NSCLC